Publications in collaboration with researchers from Universidad Complutense de Madrid (1)

2017

  1. Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: A randomised, double-blind, phase III equivalence study

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 10, pp. 1679-1687